Research
Hormonal
Pharmacological interventions for diabetes prevention are effective during active treatment but lose their efficacy immediately upon discontinuation, indicating they do not alter the underlying pathophysiology of insulin resistance or beta-cell dysfunction.
Medications can effectively prevent diabetes while you are taking them, but they do not provide long-term protection once you stop. If you discontinue medication, your risk returns to baseline. Therefore, medications are not a substitute for sustainable lifestyle changes if you plan to stop treatment.
StrongQualifiesHIGH confidence
This finding suggests that medications do not permanently alter fundamental pathophysiology of insulin resistance or β-cell dysfunction and likely only suppress hyperglycemia for the time that they are administered.
Why this rating
Meta-analysis of multiple RCTs.
Source
Long-term Sustainability of Diabetes Prevention Approaches
J. Sonya Haw et al. · JAMA Internal Medicine · 2017
DOI 10.1001/jamainternmed.2017.6040
Meta-analysis · 43 studiesCited 345×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →